Search clinical trials for: MagnetisMM
Total 15 results
-
PfizerBristol-Myers SquibbRecruiting
-
PfizerRecruiting
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
PfizerRecruiting
-
PfizerRecruitingMultiple MyelomaJapan, Taiwan, Canada, Spain, Australia, Italy, Czechia, Korea, Republic of, France, Greece, Israel, Poland, Germany
-
PfizerRecruitingMultiple MyelomaJapan, Belgium, United States, Netherlands, Australia, Austria, Taiwan, China, Spain, Canada, Korea, Republic of, Israel, Germany, Italy, Czechia, Norway, Finland, France, Sweden, Brazil, Greece, Turkey, United Kingdom, Hungary, Poland, I...
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
PfizerRecruitingMultiple MyelomaChina, Korea, Republic of, Taiwan, United States, Australia, Japan, Spain, Czechia, United Kingdom, Canada, Germany, New Zealand, Italy, France, Sweden, Poland, Netherlands, Austria, Mexico, Finland, Argentina, Belgium, Brazil, Greece, ... and more
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
PfizerCompletedMultiple MyelomaUnited States
-
PfizerActive, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Myeloma | Relapsed Multiple Myeloma | Elranatamab | PF-06863135 | BCMA | Bispecific | Bispecific Antibody | BCMA-CD3 Bispecific | MagnetisMM-8China
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Taiwan, Japan, United Kingdom
-
PfizerCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan